FRM
IBB icon

Fore Research & Management’s iShares Biotechnology ETF IBB Stock Holding History

Fore Research & Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-13,200
Closed -$1.29M – 52
2017
Q1 		$1.29M Buy
+13,200
New +$1.26M 1.59% 18

Other funds holding IBB

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fore Research & Management's IBB Position: Q2 2017 in Review

Fore Research & Management sold out of iShares Biotechnology ETF (IBB) in Q2 2017, closing a stake of 13,200 shares — an estimated $1.29M sold.

Fore Research & Management first reported a position in IBB in Q1 2017 and held it in 1 quarter. The position peaked at $1.29M in Q1 2017. 561 funds tracked by Wall St. Rank hold IBB as of Q2 2017.

  • Fore Research & Management reported no remaining iShares Biotechnology ETF position as of Q2 2017 after selling out during the quarter.
  • Fore Research & Management sold 13,200 iShares Biotechnology ETF shares in Q2 2017, an estimated $1.29M.
  • Fore Research & Management first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 1 quarter.
  • Fore Research & Management's iShares Biotechnology ETF position peaked at $1.29M in Q1 2017.
  • 561 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2017.

Based on Fore Research & Management's 13F filing for Q2 2017, filed 14 Aug 2017.